Please note: the programme is subject to change and talk titles, timings and faculty may be updated.

Monday7 DecemberTuesday8 DecemberWednesday9 December

08:35 – 08:45

Welcome and Introduction

Paul Bhogal

Venous and Glymphatics

08:45 – 09:00

The Relationship Between Venous Sinus Stenosis and Glymphatic Flow Disturbance

Stephanie Lenck

09:00 – 09:15

Should We Rely on Pressure Gradients to Inform Venous Stenting Decision-making?

Anat Horev

09:15 – 09:30

Talk Title TBC

Paddy Nicholson

09:30 – 09:45

The Acandis Acclino Flex for Venous Stenoses

Hannes Nordmeyer

09:45 – 10:00

Papilloedema Is Not the Issue

Roberto De Simone

10:00 – 10:15

The AQP4 Channel – Understanding Its Role in the Glymphatic System

Roslyn Bill

10:15 – 10:30

The Use of DTI-ALPS to Image the Glymphatic System – Is There a Role in Venous Stenting Patient Selection?

Vittorio Civelli

10:30 – 11:00

Refreshment and Exhibition

11:00 – 11:15

The Meningeal Lymphatic Vessels and Glymphatic Flow

TBC

11:15 – 11:30

Optimising CSF-Venous Fistula Treatment via CSF Catheterisation

Brian Thomas Jankowitz

11:30 – 11:45

The Impact of CSF-Venous Fistula on Glymphatic Flow

Waleed Brinjikji

11:45 – 12:00

Discussion

Headache

12:00 – 12:15

CGRP and Its Role in Headache

Tim Yates

12:15 – 12:30

Lidocaine Loaded Microspheres to Target aSAH Headache

Adnan Qureshi

12:30 – 12:45

The JnJ Migraine Study

David Fiorella

12:45 – 13:00

CGRP and Its Effects on the Meningeal Lymphatic Outflow System

Paul Bhogal

13:00 – 13:15

Short and Long-Term Outcomes of Patients with aSAH Headache Treated with MMA Lidocaine Infusion

Alex Sirakov

13:15 – 14:15

Lunch and Exhibition

MMA, Dura and Meningeal Lymphatics

14:15 – 14:30

Understanding the Immunological and Transcriptomic Aspects of cSDH

Maxim Mokin

14:30 – 14:45

Coiling of the MMA – The iCURE Study

Jan-Karl Burkhardt

14:45 – 15:00

Use of Onyx 12 to Treat cSDH

TBC

15:00 – 15:15

cSDH and MMA Embolisation – Their Role in Dementia

Pascal Jabbour

15:15 – 15:30

Embolisation of Meningiomas – Results of a Multicentre Study

Simone Peschillo

15:30 – 15:45

VEGF Inhibitors and Meningiomata – Is There a Role for VEGF Inhibitors in the Management of Meningioma?

Peter Baumgarten

15:45 – 16:15

Refreshment and Exhibition

Functional Neurointervention

16:15 – 16:30

Endovascular EEG – The Next Frontier

Vincent Costalat

16:30 – 16:45

To Push or Pull – Tracking Distally for Understanding Interventional Electroencephalography

Pascal Mossiman

16:45 – 17:00

Talk Title TBC

TBC

17:00 – 17:15

Access to the CSF Space – A New Frontier

Ajay Wakhloo

17:15 – 17:30

The Pharaoh Neuro CSF Shunt System

TBC

17:30 – 17:45

The e-Shunt – Updates on the NPH Trial and Use of Glymphatic Imaging to Optimise Patient Selection

TBC

17:45 – 18:00

What Causes NPH – The Role of the AQP4 Channel and Glymphatic Disturbance

Charles Matouk

18:00 – 18:15

Close of Meeting

08:15 – 08:30

Industry Talk

SOFIA Flow 88

Speaker: Ian Rennie, Belfast

Moderator: Hannes Nordmeyer

08:30 – 08:45

The Platelet – More Than Just Thrombosis

Alex Kauskot

08:45 – 09:00

Talk Title TBC

Simon De Meyer

09:00 – 09:15

Talk Title TBC

Karen Doyle

09:15 – 09:30

The Outer Layer of Clots – Architectural Studies and What This May Mean for Effective Thrombolysis

Mikael Mazighi

09:30 – 09:45

The IMPACT Study and How Impedance Technology Can Improve FPE

Vincent Costalat

09:45 – 10:00

AI Based Radiomics to Predict Underlying Clot Histology

Anna Maria Merel Boers

10:00 – 10:15

Imaging of NETs Within Clots – The Need for Dedicated Contrast Agents

Matthew Gounis

10:15 – 10:30

How Clot Structure Impacts the Success of Standard Lytic Agents and the Need to Tailor Lytics to Clot Composition

David Liebeskind

10:30 – 11:00

Refreshment and Exhibition

11:00 – 11:15

What Next for MeVO?

Johanna Ospel

11:15 – 11:30

The Thunder Study

David Fiorella

11:30 – 11:45

The Neva 3mm SR – Early FIH Results

Johannes Pfaff

11:45 – 12:00

Born to Adapt: FIH Experience with Adaptive-Tip Aspiration Catheter

Sarah Power

12:00 – 12:15

QLCT Technology and Its Clinical Implications in Neuroendovascular Care

Kaustubh Limaye

12:15 – 12:30

Comparison of Cyclic Aspiration with SuperBore and Standard Large Bore Aspiration

Ameer Hassan

12:30 – 12:45

The MicroAspiration Retrieval System: MARS Device for Distal Vessel Occlusions

Jiahui Li

12:45 – 13:00

Update on Quantanosis

Ameer Hassan

13:00 – 14:00

Lunch and Exhibition

Improving Stroke Outcomes: Stem Cells

14:00 – 14:15

Stem Cell Types for Acute Stroke Treatment

Keith Muir

14:15 – 14:30

First in Human IA Cell Therapy for Acute Stroke Locked-In Syndrome

TBC

14:30 – 14:45

Extracellular Vesicles in Intravascular Cell Therapy for Acute Stroke

Dirk Hermann

14:45 – 15:00

Basic Science Investigations in IA Cell Therapy for Acute Stroke

Piotr Walczak

Improving Stroke Outcomes: Hypothermia Treatment

15:00 – 15:15

The Future of Stroke Care

Paul Bhogal, Marc Ribo, Wim van Zwam, Peter Zampakis

15:15 – 15:30

An Update on Brain Cooling for the Stroke

Wim van Zwam

15:30 – 15:45

Hybernia – The Latest Results

Jae Choi

15:45 – 16:15

Refreshment and Exhibition

16:15 – 16:30

Latest Update on the P8RI Stent-Coating

Aymeric Rouchaud

16:30 – 16:45

Electrospinning – What Is It?

Teodor-Matei Cirstea

16:45 – 17:00

The TUBE Electrospun Stent – FIM Results

Satoshi Tateshima

17:00 – 17:15

A Re-Sheathable Open Cell Aneurysm Bridging Stent

TBC

AVMs

17:15 – 17:30

The Latest and Greatest from Galaxy Seal

Sam Zaidat

17:30 – 17:45

The p48 HPC LT – Low Profile Flow Diverter for Improved Access

Hans Henkes

17:45 – 18:00

Core Lab Adjudicated Results of the Pivotal French eCLIPS Study

TBC

18:00 – 18:15

Early Clinical Experience with a Novel Chinese Developed Intrasaccular Device for Intracranial Aneurysm Treatment

TBC

18:15 – 18:30

Thin Film Nitinol Flow Diversion Technology

Pedro Lylyk Jnr

18:30 – 18:45

Final Results of the TORNADO Study

TBC

08:30 – 08:45

What Have We Learned About ICAD Recently

Jens Fiehler

08:45 – 09:00

Final Results of the Japanese TG Dilator Device

Nobuyuki Sakai

09:00 – 09:15

What Does CFD Tell Us About Optimal Recanalisation Rates in ICAD?

Leonard Yeo

09:15 – 09:30

FIH Results with the Novel Ceroflo Submax Stent Technology

TBC

09:30 – 09:45

The Cause of In Stent Stenosis

TBC

Giant Aneurysms / Vertebrobasilar Aneurysms

09:45 – 10:00

Neovascularisation of Giant and Partially Thrombosed Aneurysms – Pathology and Histopathology

Michihiro Tanaka

10:00 – 10:15

The Prognosis of Vertebrobasilar Non-Saccular Aneurysms

Mika Niemelä

10:15 – 10:30

Targeting the Neoangiogenesis in the Wall with VEGF Inhibitors

Rahul Kumar

10:30 – 10:45

Endovascular Strategies for Dealing with Non-Saccular Giant Vertebrobasilar Aneurysms

TBC

10:45 – 11:15

Refreshment and Exhibition

Aneurysmal Disease and SAH

11:15 – 11:30

The Evolution of Vascular Navigation

TBC

11:30 – 11:45

SightEndo – The Future INR Suite

Gal Yaniv

11:45 – 12:00

The Artiria Robotic Microwire

Guillaume Petit-Pierre

12:00 – 12:15

Carotid Plaque AI

TBC

12:15 – 12:30

Beyond the Lumen: What Angiography Has Been Hiding From Us

Demetrius Lopes

12:30 – 12:45

OCT – Talk Title TBC

TBC

12:45 – 13:00

Talk Title TBC

TBC

13:00 – 14:00

Lunch and Exhibition

14:00 – 14:15

In Vivo Modelling of AVM Pathogenesis and Testing of Novel Agents

Ivan Radovanovic

14:15 – 14:30

A Novel UV Activated Liquid Embolic

Hal Rice

14:30 – 14:45

Use of IA Bevacizumab in AVM Treatments

Frédéric Clarençon

14:45 – 15:00

GLP1 Receptor Agonists – Potential Role in Stroke and Aneurysmal Disease

Lucie Thibault

15:00 – 15:15

Update on the NET Removal System

Andrew Aswani

15:15 – 15:30

Talk Title TBC

TBC

15:30 – 15:45

Talk Title TBC

TBC

Neuro OCT

15:45 – 16:00

Talk Title TBC

TBC

16:00 – 16:15

Talk Title TBC

TBC

16:15 – 16:30

Talk Title TBC

TBC

16:30 – 16:35

Close of Meeting

Follow us on: